MRI‐Derived Lymph Nodes Morphological and Topological Structure (LNs‐MTS) Model for Evaluating Immune Status and Prognosis in Rectal Cancer
Open Access
- 31 August 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (39) , e06523
Abstract
Tumor‐draining lymph nodes (LNs) immune status critically influences cancer progression and treatment response, yet reliable non‐invasive assessment remains clinically unavailable. To address this critical gap, an MRI‐derived LNs morphological and topological structure (LNs‐MTS) model is developed to evaluate the immune status of LNs in rectal cancer (RC). Integrating multicenter imaging, transcriptomic, and immunohistochemical data from 1,156 stage I‐II RC patients, enhanced immune activation in non‐metastatic LNs sized ≥0.5 cm and located ≥5 cm from the primary tumor is discovered. Then two quantitative MRI‐derived imaging features across 7,030 radiologically annotated LNs: total LNs volume (tLNV) and total LNs drainage distance (tLND) is developed, forming the basis of the LNs‐MTS model risk subtypes: high‐risk (HRS), moderate‐risk (MRS), and low‐risk (LRS). Patients in the LRS (characterized by large tLNV and distant tLND) show robust immune cell infiltration in the tumor microenvironment and excellent 5‐year survival, whereas HRS (characterized by small tLNV and near tLND) show stromal dominance and poorer prognosis. Clinically, LNs‐MTS offers a more precise and personalized risk assessment than current guideline‐based risk stratification, potentially sparing stage II‐LRS patients from unnecessary adjuvant treatment while identifying stage I‐HRS individuals for more aggressive treatment, providing valuable insights for personalized treatment strategies in RC management.Keywords
Funding Information
- National Natural Science Foundation of China (U23A20482)
- National Natural Science Foundation of China (62276084)
- National Natural Science Foundation of China (82202269)
This publication has 33 references indexed in Scilit:
- Let it be: Preserving tumor-draining lymph nodes in the era of immuno-oncologyCancer Cell, 2024
- The pre-metastatic niche in lymph nodes: formation and characteristicsCellular and Molecular Life Sciences, 2021
- The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph NodesCancer Cell, 2020
- Large negative lymph nodes – a surrogate for immune activation in rectal cancer patients?Pathology - Research and Practice, 2020
- KEGG Mapper for inferring cellular functions from protein sequencesProtein Science, 2019
- Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune responseBiomaterials, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Vascular remodeling in cancerOncogene, 2013
- VEGF-C Promotes Immune Tolerance in B16 Melanomas and Cross-Presentation of Tumor Antigen by Lymph Node LymphaticsCell Reports, 2012
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009